Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effect of diurnal variation on debrisoquine metabolic phenotyping.

Journal of the National Cancer Institute - 3 Oct 1990

Shaw G L, Falk R T, Caporaso N E, Issaq H J, Kase R G, Fox S D, Tucker M A

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Circadian Rhythm
Share to Debrisoquin
Share to Eating
Share to Fasting

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Isoquinolines

Share to Phenotype

Share to Reference Values

Source

Identifiers

PMID: 2402018
DOI: 10.1093/jnci/82.19.1573

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effect of diurnal variation on debrisoquine metabolic phenotyping.PMID 2402018Read ↗

Determination of debrisoquine oxidation phenotype in healthy volunteers during phase I trials.Semantic proximity Read ↗

Rapid high-performance liquid chromatographic method for determination of debrisoquine and 4-hydroxy-debrisoquine in urine for CYP2D6 phenotyping.Semantic proximity Read ↗

Polymorphic debrisoquine oxidation and acute neuroleptic-induced adverse effects.Semantic proximity Read ↗

Correlation between the metabolic ratios of debrisoquine and metoprolol in Turkish subjects.Semantic proximity Read ↗

Ten percent of North Spanish individuals carry duplicated or triplicated CYP2D6 genes associated with ultrarapid metabolism of debrisoquine.Semantic proximity Read ↗

Pharmacogenetics of Debrisoquine and its Use as a Marker For CYP2D6 Hydroxylation CapacitySemantic proximity Read ↗

Metabolism of almitrine in extensive and poor metabolisers of debrisoquine/sparteine.Semantic proximity Read ↗

Disposition of debrisoquine in Caucasians with different CYP2D6-genotypes including those with multiple genes.Semantic proximity Read ↗

Haloperidol disposition is dependent on debrisoquine hydroxylation phenotype.Semantic proximity Read ↗

Influence of debrisoquine hydroxylation phenotype on the pharmacokinetics of mexiletine.Semantic proximity Read ↗

Evidence for the polymorphic oxidation of debrisoquine in the Thai population.Semantic proximity Read ↗

Salivary analysis for determination of dextromethorphan metabolic phenotype.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.